Changing prognosis of metastatic colorectal adenocarcinoma: Differential improvement by age and tumor location

Cetuximab-based therapy in elderly comorbid patients with metastatic colorectal cancer

(2012) C F Jehn et al.   BRITISH JOURNAL OF CANCER

Cancer statistics, 2012

(2012) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Limited utility despite accuracy of the national SEER dataset for the study of craniopharyngioma

(2012) Todd C. Hankinson et al.   JOURNAL OF NEURO-ONCOLOGY

Bevacizumab is equally effective and no more toxic in elderly patients with advanced colorectal cancer: a subgroup analysis from the AGITG MAX trial: an international randomised controlled trial of Capecitabine, Bevacizumab and Mitomycin C

(2011) T. J. Price et al.   ANNALS OF ONCOLOGY

Impact of age on choice of chemotherapy and outcome in advanced colorectal cancer

(2011) Muhammad A. Khattak et al.   EUROPEAN JOURNAL OF CANCER

Evaluation of Long-term Survival After Hepatic Resection for Metastatic Colorectal Cancer

(2009) Myrddin Rees et al.   ANNALS OF SURGERY

Treatment of the elderly colorectal cancer patient: SIOG expert recommendations

(2008) D. Papamichael et al.   ANNALS OF ONCOLOGY

Effects of Socioeconomic Status and Treatment Disparities in Colorectal Cancer Survival

(2008) H. Le et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Addition of Bevacizumab to Fluorouracil-Based First-Line Treatment of Metastatic Colorectal Cancer: Pooled Analysis of Cohorts of Older Patients From Two Randomized Clinical Trials

(2008) Fairooz F. Kabbinavar et al.   JOURNAL OF CLINICAL ONCOLOGY

Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer

(2008) Carsten Bokemeyer et al.   JOURNAL OF CLINICAL ONCOLOGY

Disparities in the Use of Chemotherapy and Monoclonal Antibody Therapy for Elderly Advanced Colorectal Cancer Patients in the Community Oncology Setting

(2008) T. McKibbin et al.   ONCOLOGIST